The mean number of IFN-ɣ–producing T cells from COVID-19 patients nearly doubled, from 101 ± 21 to 201 ± 36 (P < 0.0001), following ex vivo administration of IL-7 (Figure 8A). Here, IL7 is linked to COVID-19.